Background/Aims: Controversy exists regarding 3- or 4 drug antituberculosis therapy (conventional ATT) in uveitis patients having latent tuberculosis (LTB), especially while initiating therapy with corticosteroids and/or other immunosuppressants. Methods: We performed a monocentral retrospective analysis of posterior uveitis patients with latent TB. Latent TB was diagnosed, in case of a positive QuantiFERON®-TB-Gold test and normal chest imaging, after ruling out other causes of infectious and noninfectious uveitis. Patients with active TB were excluded. From 2016 to 2020 we included 17 patients. Ophthalmological evaluation consisted of Best corrected visual acuity (BCVA), slit lamp examination, fundoscopy, OCT, and fluorescein- and indocyaningreen- angiography before and at months 3, 6, 12, 24, and the last follow-up after treatment. Results: Initially, all patients had active posterior uveitis with occlusive (n = 5 patients) and nonocclusive retinal vasculitis (n = 12 patients). Mean follow up was 28 ± 15 months. Therapy was started with systemic corticosteroids (mean prednisolone equivalent 71.3 mg/d) and already after 3 months it could be tapered to a mean maintenance dosage of 8.63 mg/d. Additional immunosuppressive treatment with cs- or bDMARDs was initiated in 14 patients (82%) due to recurrences of uveitis while tapering the corticosteroids <10 mg per/day or because of severe inflammation at the initial visit. While being on immunosuppression, best corrected visual acuity increased from 0.56 logMAR to 0.32 logMAR during follow-up and only three patients had one uveitis relapse, which was followed by switch of immunosuppressive treatment. As recommended, TB prophylaxis with 300 mg/d isoniazid was administered in 11 patients for at least 9 months while being on TNF-alpha-blocking agents. No patient developed active tuberculosis during immunosuppressive therapy. Conclusion: Mainly conventional ATT is strongly recommended—as monotherapy or in combination with immunosuppressives—for effective treatment in patients with uveitis due to latent TB. Although in our patient group no conventional ATT was initiated, immunosuppression alone occurred as an efficient treatment. Nevertheless, due to possible activation of TB, isoniazid prophylaxis is mandatory in latent TB patients while being on TNF-alpha blocking agents.
2 July 2019 in Klinische Monatsblätter für Augenheilkunde
Morbus Wilson ist eine seltene genetische Erkrankung des Kupferstoffwechsels, die zu einer erhöhten Kupferansammlung im Körper führt. Ablagerungen finden sich vor allem in Leber, zentralem Nervensystem, Niere und Auge. Unbehandelt kann die Erkrankung zu Bewegungsstörungen, Persönlichkeitsveränderungen, Leberversagen bis hin zum Tod führen. Differenzialdiagnostisch kommen viele Erkrankungen infrage. Eine Diagnosefindung ist nur durch spezifische Testverfahren möglich. Der Augenarzt hat somit eine besondere Rolle in der Früherkennung eines Morbus Wilson. In unserer Klinik stellte sich eine 19-jährige Patientin mit einem schwachen, im Verlauf entstehenden Kayser-Fleischer-Kornealring mit sonst unauffälligem ophthalmologischen Befund vor. Die Patientin hatte ein progredientes Leberversagen und erhielt 2 Monate nach Erstvorstellung in der Augenklinik eine Lebertransplantation. Eine frühzeitige augenärztliche Mitbeurteilung mit gründlicher Untersuchung ist von entscheidender Bedeutung für eine schnelle Diagnosestellung. Die Kupferablagerungen finden sich in der Descemet-Membran und beginnen in der Schwalbe-Linie. Der sog. Kayser-Fleischer-Ring zeigt sich an der Descemet-Membran bis zu 5 mm vom Limbus entfernt. Andere mögliche ophthalmologische Manifestationen stellen eine Chalkose der gesamten Descemet, ein Ikterus der Skleren oder eine Sonnenblumenkatarakt dar. Bei fehlenden Kupferablagerungen im Spaltlampenbefund sollte bei einem Verdacht auf einen Morbus Wilson immer auch eine Gonioskopie des Kammerwinkels erfolgen. Eine frühe Diagnosestellung kann Patienten vor unnötigen Komplikationen und Operationen schützen. Behandelt hat der Morbus Wilson eine gute Prognose. Wilsonʼs disease is a rare genetic disease of copper metabolism that leads to increased accumulation of copper in the body. Deposits are found mainly in the liver, brain and eye. If left untreated, the disease can lead to movement disorders, personality changes, liver failure and even death. There are many possible differential diagnoses. Diagnosis can only be made through specific test procedures. The ophthalmologist therefore has a special role in the early detection of a Wilsonʼs disease. In our clinic, a 19-year old female patient presented with a faint Kayser-Fleischer corneal ring with otherwise normal ophthalmological findings. The patient had progressive liver failure and received a liver transplant two months after first presentation in the eye clinic. An early ophthalmological co-evaluation with a thorough examination is of great importance for rapid diagnosis. The copper deposits are found in the Descemet membrane and begin in the Schwalbeʼs line. The so-called Kayser-Fleischer ring can be seen on the Descemet membrane up to 5 mm away from the limbus. Other possible ophthalmological manifestations are chalcosis of the entire Descemet, icterus of the sclera or a sunflower cataract. In the absence of copper deposits in the slit lamp examination, gonioscopy should always be performed if Wilsonʼs disease is suspected. Early diagnosis can protect patients from unnecessary complications and operations. Wilsonʼs disease has a good prognosis if treated.